Filed by the Registrant
|
|
|
☒
|
Filed by a Party other than the Registrant
|
|
|
☐
|
Check the appropriate box:
|
☐ |
Preliminary Proxy Statement
|
☐ |
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
☐ |
Definitive Proxy Statement
|
☒ |
Definitive Additional Materials
|
☐ |
Soliciting Material Pursuant to Section240.14a-12
|
Health Sciences Acquisitions Corporation 2
|
|
(Name of Registrant as Specified in Its Charter)
|
|
|
|
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
|
|
Payment of Filing Fee (Check all boxes that apply):
|
|
|
|
☒ |
No fee required
|
|
|
☐ |
Fee paid previously with preliminary materials.
|
|
|
☐ |
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
1.
|
Option 1, YES to Extend and no Redemption: Vote YES for the extension and take no redemption actions. You keep the opportunity to vote on the proposed business combination and to redeem your shares in a second redemption opportunity related to the
proposed business combination at a later date (expected in 4Q 2022).
|
2.
|
Option 2, YES to Extend but Redeem: Vote YES for the extension and redeem your shares by July 22. In doing so, you will lose the opportunity to participate in the proposed business combination.
|
3.
|
Option 3, NO to Extend and Redeem: Vote NO for the extension and redeem your shares by July 22. In doing so, you will lose the opportunity to participate in the proposed business combination.
|